Oncolytics Bio (ONC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 7,455 | 6,155 | 6,724 | 5,901 | 8,072 |
| Operating Income | -7,455 | -6,155 | -6,724 | -5,901 | -8,072 |
| Other Income | -254 | 1,290 | -522 | -534 | -1,256 |
| Pre-tax Income | -7,709 | -4,865 | -7,246 | -6,435 | -9,329 |
| Income Tax | 42 | 7 | 0 | N/A | 0 |
| Net Income Continuous | -7,751 | -4,872 | -7,246 | -6,435 | -9,329 |
| Net Income | $-7,751 | $-4,872 | $-7,246 | $-6,435 | $-9,329 |
| EPS Basic Total Ops | -0.14 | -0.09 | -0.13 | -0.13 | -0.22 |
| EPS Basic Continuous Ops | -0.14 | -0.09 | -0.13 | -0.13 | -0.22 |
| EPS Diluted Total Ops | -0.14 | -0.09 | -0.13 | -0.13 | -0.22 |
| EPS Diluted Continuous Ops | -0.14 | -0.09 | -0.13 | -0.13 | -0.22 |
| EBITDA(a) | $-7,358 | $-6,070 | $-6,560 | $-5,794 | $-7,965 |